Vega Jovani-Casano

Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group.

C. Esquinas, M. Cordero-Coma, A. Adán, 2019, Ophthalmology.